Diabetes Drugs Safe from Thyroid Cancer Risk, S...

By Rene Pretorius

January 7, 2025

The recent cohort study examined whether use of glucagon-like peptide 1 (GLP1) receptor agonists is associated with increased risk of thyroid cancer. By investigating this important issue, the
Thyroid Eye Disease Therapy: Insights from Viridian Therapeutics’ THRIV...
Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prev...
Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak
BioSapien Innovative Cancer Drug Delivery Solutions
Lenacapavir Injection: A Breakthrough in Global HIV Prevention
Transforming Cancer Care in Abu Dhabi
Improving Access to Trikafta for Cystic Fibrosis Patients in South Africa
Promising Results for Imlunestrant in Advanced ER+ HER2- Breast Cancer
AI Tool Predicts Type 2 Diabetes Risk via ECG Up to 10 Years Early
Heplisav-B: A Superior Hepatitis B Vaccine for Individuals with HIV
Egypt’s Hepatitis C Program: A Model for Africa’s Health Initiatives
Advancing the 95-95-95 Targets: A Roadmap to End AIDS by 2030